These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9811359)

  • 1. CholecystokininB receptor antagonist increases food intake in rats.
    Dorré D; Smith GP
    Physiol Behav; 1998 Aug; 65(1):11-4. PubMed ID: 9811359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of amygdala cholecystokininB receptors potentiates the acoustic startle response in the rat.
    Frankland PW; Josselyn SA; Bradwejn J; Vaccarino FJ; Yeomans JS
    J Neurosci; 1997 Mar; 17(5):1838-47. PubMed ID: 9030642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
    Singh L; Field MJ; Hughes J; Menzies R; Oles RJ; Vass CA; Woodruff GN
    Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous infusion of CCKA-receptor antagonist increases food intake in rats.
    Miesner J; Smith GP; Gibbs J; Tyrka A
    Am J Physiol; 1992 Feb; 262(2 Pt 2):R216-9. PubMed ID: 1539728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of central nervous system activity of systemically administered CCKB receptor antagonists by ex vivo binding.
    Patel S; Chapman KL; Heald A; Smith AJ; Freedman SB
    Eur J Pharmacol; 1994 Mar; 253(3):237-44. PubMed ID: 8200418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of centrally administered CCK-receptor antagonists on food intake in rats.
    Corp ES; Curcio M; Gibbs J; Smith GP
    Physiol Behav; 1997 Jun; 61(6):823-7. PubMed ID: 9177553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of N- and C-terminal substituents on the CCK-B agonist-antagonist pharmacological profile of Boc-Trp-Phg-Asp-Nal-NH2 derivatives.
    Weng JH; Blommaert AG; Moizo L; Bado A; Ducos B; Böhme A; Garbay C; Roques BP
    Bioorg Med Chem; 1996 Apr; 4(4):563-73. PubMed ID: 8735845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral effects of CCKB receptor ligands in a validated simulation of panic anxiety in rats.
    Jenck F; Martin JR; Moreau JL
    Eur Neuropsychopharmacol; 1996 Nov; 6(4):291-8. PubMed ID: 8985712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat.
    Hayward NJ; Harding M; Lloyd SA; McKnight AT; Hughes J; Woodruff GN
    Br J Pharmacol; 1991 Dec; 104(4):973-7. PubMed ID: 1687371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.
    Singh L; Lewis AS; Field MJ; Hughes J; Woodruff GN
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1130-3. PubMed ID: 1996314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158.
    Tsutsumi T; Akiyoshi J; Isogawa K; Kohno Y; Hikichi T; Nagayama H
    Neuropeptides; 1999 Dec; 33(6):483-6. PubMed ID: 10657528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YM022, a highly potent and selective CCKB antagonist inhibiting gastric acid secretion in the rat, the cat and isolated rabbit glands.
    Attoub S; Moizo L; Laigneau JP; Alchepo B; Lewin MJ; Bado A
    Fundam Clin Pharmacol; 1998; 12(3):256-62. PubMed ID: 9646057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weak tolerance to the antinociceptive effect induced by the association of a peptidase inhibitor and a CCKB receptor antagonist.
    Valverde O; Blommaert AG; Fournié-Zaluski MC; Roques BP; Maldonado R
    Eur J Pharmacol; 1995 Nov; 286(1):79-93. PubMed ID: 8566154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CCKB antagonist CI988 reduces food intake in fasted rats via a dopamine mediated pathway.
    Frommelt L; Lembke V; Hofmann T; Goebel-Stengel M; Mönnikes H; Wiedenmann B; Klapp BF; Stengel A; Kobelt P
    Peptides; 2013 Jan; 39():111-8. PubMed ID: 23200724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin A receptor antagonist inhibits feed memory in Japanese quail.
    Berthelot V; Belzung C; Meunier-Salaun MC; Nowak R; Picard M
    Physiol Behav; 1996 Aug; 60(2):575-9. PubMed ID: 8840921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modulation of alpha 2-adrenergic and opioid spinal antinociception by cholecystokinin and cholecystokinin antagonists in the rat dorsal horn: an electrophysiological study.
    Sullivan AF; Hewett K; Dickenson AH
    Brain Res; 1994 Oct; 662(1-2):141-7. PubMed ID: 7859067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI-988.
    Singh L; Field MJ; Vass CA; Hughes J; Woodruff GN
    Br J Pharmacol; 1992 Jan; 105(1):8-10. PubMed ID: 1350747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracerebroventricular cholecystokinin A-receptor antagonist does not reduce satiation by endogenous CCK.
    Brenner LA; Ritter RC
    Physiol Behav; 1998 Feb; 63(4):711-6. PubMed ID: 9523920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of ex vivo binding to estimate brain penetration and central activity of CCK-B antagonists.
    Patel S; Chapman KL; Smith AJ; Heald A; Freedman SB
    Ann N Y Acad Sci; 1994 Mar; 713():360-3. PubMed ID: 8185188
    [No Abstract]   [Full Text] [Related]  

  • 20. His381 of the rat CCKB receptor is essential for CCKB versus CCKA receptor antagonist selectivity.
    Jagerschmidt A; Guillaume-Rousselet N; Vikland ML; Goudreau N; Maigret B; Roques BP
    Eur J Pharmacol; 1996 Jan; 296(1):97-106. PubMed ID: 8720482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.